SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Medix (MDIX) - competitor to Healtheon - $0.25/share

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BlueCheap who wrote (11)4/15/1999 1:27:00 PM
From: gtc123   of 16
 
MediConsult (MCNS) is in the consumer health information space. They are trying to be the consumer health portal. I think they're worth around $250MM. Congrats on catching that meteoric rise. I would say that the market Medix is attacking is many multiples larger than consumer health information. Medix is attempting to web enable all the transactions between healthcare providers, payors, and patients. The opportunity is very large given the $1TT size of the healthcare industry. That's why Healtheon is valued at $3BB for basically having a product in beta. It's a very large opportunity. That's why there is so much upside potential in Medix because they are valued at $15MM, even though they are *close* to launching with Wellpoint. If Wellpoint falls apart, we're in trouble. But, if they hit on all cylinders at Wellpoint, well, then this *could* generate returns well beyond that of MCNS. This is a much bigger opportunity. That's why I don't think that stock report picking a $5 near-term price and a $15 long-term price is unrealistic. There's a legitimate shot. They have lots of work to do, and it sounds like some things may transpire over the next few weeks, so those targets feel pretty reachable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext